Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin Lymphoma

Cancer Biotherapy & Radiopharmaceuticals , Vol. 0, No. 0.


from Cancer via ola Kala on Inoreader http://ift.tt/2hohl5e
via IFTTT